carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
generic drug updates
Launch of Generic Relpax
Released: 07/25/2017
By: Heidi Dufrene, PharmD

The generic equivalent of Relpax (Eletriptan) has just been released, following FDA approval. Relpax is FDA-approved for the acute treatment of migraine with or without an aura in adults. Eletriptan will be available in 20 and 40mg strengths.

All generic drugs approved by the FDA have the same quality, strength, purity and stability as brand name drugs. The generic manufacturing, packaging and testing sites must pass the same quality standards as those of brand name drugs.

Please contact us at 800-553-1783 or at pharmacy@carlislemedical.com if you have any questions on this announcement or if our pharmacy staff may assist you in any way.

<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2017 Carlisle & Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer